Lexeo Therapeutics (NASDAQ:LXEO) outlined its approach to evaluating LX2020, an investigational AAVrh10-based gene therapy for PKP2-associated arrhythmogenic cardiomyopathy, or ACM, ahead of an ...
Lunit Inc. (KRX: 328130) and Summit Therapeutics Inc. (NASDAQ: SMMT) today announced a research agreement to evaluate the use ...
Researchers have developed software that enables 3D-printed objects to sense and respond to human movements. The system, ...
Summary] What this article aims to conveyIn business system development, there is a frequent tendency to easily delegate ...
Anthropic Guest Investigators program opens a 14-day application window for academic principal investigators to collaborate ...
Huawei's Ascend has been integrated into the code supporting DeepSeek's AI.Support is expanding beyond matrix calculations to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results